Related Experiment Video
Updated: Aug 1, 2025
04:36
Noninvasive Electrocardiography in the Perinatal Mouse
Published on: June 12, 2020
6.1K
Peripartum Cardiomyopathy in a Multigravida Patient.
Mitchell Cross1, Joel H Schirding1, Kristina Domanski1
1Emergency Medicine, University Medical Center, Las Vegas, USA.
Cureus
|April 24, 2023
Summary
Peripartum cardiomyopathy (PPCM) is a rare heart condition affecting pregnant or postpartum women. This case report details a multigravida patient, highlighting the need for better understanding and early PPCM diagnosis.
Area of Science:
- Cardiology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Peripartum cardiomyopathy (PPCM) is a serious pregnancy-associated heart condition.
- It typically manifests in late pregnancy or early postpartum.
- PPCM's pathophysiology and risk factors are not fully understood.
Observation:
- This case report details a multigravida patient with a history of 12 pregnancies.
- The patient presented with no significant past medical history, except for pre-eclampsia.
- This highlights a unique clinical presentation within the context of PPCM.
Findings:
- PPCM diagnosis and management can be challenging due to limited data.
- The case underscores the importance of considering PPCM in women with cardiovascular symptoms during or after pregnancy.
- Multigravida status and prior pre-eclampsia may be relevant factors.
Implications:
- Enhanced understanding of PPCM pathophysiology is crucial for improved patient outcomes.
- Early recognition and prompt treatment initiation are key to managing PPCM effectively.
- This case contributes valuable clinical insights to the existing medical literature on PPCM.
Keywords:
acute decompensated systolic heart failureemergency medicine resuscitationgeneral obgynmultigravidaperipartum cardiomypathyperipartum dilated cardiomyopathyppcmMore Related Videos
Related Concept Videos
01:19Mitral Valve Prolapse III: Nursing Management
22
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
22
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
13
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
13
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
18
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
01:30Cardiomyopathy II: Dilated Cardiomyopathy
13
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
18
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
18
01:25Cardiomyopathy I: Introduction and Classification
26
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
26